Endoscopic ultrasound‐rendezvous versus percutaneous‐endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta‐analysis
Digestive Endoscopy · 2024
DOI: 10.1111/den.14636 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Digestive Endoscopy, 2024. Verfasst von Seung Bae Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Cholestasis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objectives
Endoscopic ultrasound (EUS) or percutaneous‐assisted antegrade guidewire insertion can be used to achieve biliary access when standard endoscopic retrograde cholangiopancreatography (ERCP) fails. We conducted a systematic review and meta‐analysis to evaluate and compare the effectiveness and safety of EUS‐assisted rendezvous (EUS‐RV) and percutaneous rendezvous (PERC‐RV) ERCP.
Methods
We searched multiple databases from inception to September 2022 to identify studies reporting on EUS‐RV and PERC‐RV in failed ERCP. A random‐effects model was used to summarize the pooled rates of technical success and adverse events with 95% confidence interval (CI).
Results
In total, 524 patients (19 studies) and 591 patients (12 studies) were managed by EUS‐RV and PERC‐RV, respectively. The pooled technical successes were 88.7% (95% CI 84.6–92.8%, I 2 = 70.5%) for EUS‐RV and 94.1% (95% CI 91.1–97.1%, I 2 = 59.2%) for PERC‐RV ( P = 0.088). The technical success rates of EUS‐RV and PERC‐RV were comparable in subgroups of benign diseases (89.2% vs. 95.8%, P = 0.068), malignant diseases (90.3% vs. 95.5%, P = 0.193), and normal anatomy (90.7% vs. 95.9%, P = 0.240). However, patients with surgically altered anatomy had poorer technical success after EUS‐RV than after PERC‐RV (58.7% vs. 93.1%, P = 0.036). The pooled rates of overall adverse events were 9.8% for EUS‐RV and 13.4% for PERC‐RV ( P = 0.686).
Conclusions
Both EUS‐RV and PERC‐RV have exhibited high technical success rates. When standard ERCP fails, EUS‐RV and PERC‐RV are comparably effective rescue techniques if adequate expertise and facilities are feasible. However, in patients with surgically altered anatomy, PERC‐RV might be the preferred choice over EUS‐RV because of its higher technical success rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
- Department of Gastroenterology, Ajou University School of Medicine, Suwon, South Korea.
- Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea.
- Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea.
ORCID-Profile: Seung Bae Yoon, Min Jae Yang, Sung-Hoon Moon
Zitieren
APA
Yoon, S. B., Yang, M. J., Shin, D. W., Soh, J. S., Lim, H., Kang, H. S., & Moon, S. H. (2024). Endoscopic ultrasound‐rendezvous versus percutaneous‐endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta‐analysis. Digestive Endoscopy. https://doi.org/10.1111/den.14636
Vancouver
Yoon SB, Yang MJ, Shin DW, Soh JS, Lim H, Kang HS, et al. Endoscopic ultrasound‐rendezvous versus percutaneous‐endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta‐analysis. Digestive Endoscopy. 2024. doi:10.1111/den.14636
BibTeX
@article{Yoon2024,
author = {Yoon, Seung Bae and Yang, Min Jae and Shin, Dong Woo and Soh, Jae Seung and Lim, Hyun and Kang, Ho Suk and Moon, Sung-Hoon},
title = {Endoscopic ultrasound‐rendezvous versus percutaneous‐endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta‐analysis},
journal = {Digestive Endoscopy},
year = {2024},
doi = {10.1111/den.14636}
}
EUVIMED